Robinhood Markets, Inc.’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$106 Buy
+116
New +$125 ﹤0.01% 1113

Other funds holding AKBA

Robinhood Markets, Inc.'s AKBA Position: Q3 2026 in Review

Robinhood Markets, Inc. opened a new position in Akebia Therapeutics (AKBA) in Q3 2026: 116 shares worth $106. The stake represents ﹤0.01% of the portfolio and ranks #1113 among its holdings.

157 funds tracked by Wall St. Rank hold AKBA as of Q3 2026.

  • Robinhood Markets, Inc. held 116 shares of Akebia Therapeutics worth $106 as of Q3 2026.
  • Akebia Therapeutics was a new Robinhood Markets, Inc. position in Q3 2026.
  • Akebia Therapeutics made up ﹤0.01% of Robinhood Markets, Inc.'s portfolio in Q3 2026, its #1113 holding.
  • 157 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q3 2026.

Based on Robinhood Markets, Inc.'s 13F filing for Q3 2026, filed 18 Nov 2026.